Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Towards medical treatments using cell level control

01.11.2012
Researchers at Tokyo Institute of Technology and the Weizmann Institute of Science identify a means of controlling biological processes that could help treatments for immune disease, neurological disorders and cancer.
Researchers at Tokyo Institute of Technology and the Weizmann Institute of Science identify a means of controlling biological processes that could help treatments for immune disease, neurological disorders and cancer.

The cellular response to a number of signals including inflammatory cytokines, tumor promoters, carcinogens, and chemotherapeutic agents hinge on the transcription factor NF-êB. Rivka Dikstein and colleagues at Tokyo Institute of Technology in Japan and the Weizmann Institute of Science in Israel identify how the protein DSIF controls NF-êB activity. The research may lead to methods for controlling inflammation, and immune responses, as well as the cell cycle processes that can lead to cancer.
Activity of NF-êB is usually transient because some of the gene products function as negative regulators of NF-êB, resulting in a negative feedback loop (Figure 1). This is desirable because persistent activation of NF-êB can lead to various pathogenic conditions such as chronic inflammation, autoimmune diseases, and cancer.

Dikstein and colleagues treated cells to reduce the expression of DSIF and monitored the effect on protein levels of NF-êB’s target genes. They found that in the treated ‘DSIF knockdown’ cells the levels of these proteins failed to recover following a degradation process. Further investigation revealed that DSIF plays an integral role in the maturation and transport of messenger RNAs (Figure 2).

“The unique control of the negative feedback regulator genes by DSIF may be utilized by cells under circumstances in which prolonged NF-êB activity is needed,” explain the authors. Their future studies will focus on DSIF under specific settings with a view to identifying drug targets for selective manipulation of NF-êB activity.

BACKGROUND

NF-êB induces gene expression responsible for a number of biological processes including inflammation and cell survival. Its deregulation is linked to chronic inflammation and cancer but so far the mechanisms behind these processes have not been fully understood.

Nuclear transport is integral to NF-êB activity. In unstimulated cells it is retained inactive in the cytoplasm. Signals that trigger its activation result in its transport into the nucleus where it activates responsive genes, such as A20 and IêBá.

Figure 1. Negative feedback regulation of inflammatory responses. The transcription factor NF-êB activates transcription of its target genes, such as A20 and IêBá. Products of these genes function as negative regulators of NF-êB and limit the duration of its activation. This is desirable because persistent activation of NF-êB can lead to various pathogenic conditions such as chronic inflammation, autoimmune diseases, and cancer.


Figure 2. The role of DSIF in the control of inflammatory responses. Upon NF-êB activation, DSIF is recruited to the A20 and IêBá genes and contributes to the negative feedback regulation in a unique manner. DSIF facilitates the expression of these genes by stimulating capping, splicing, and export of their mRNAs. Otherwise, these steps are rate-limiting, and A20 and IêBá proteins are not synthesized successfully.

Activity of NF-êB is usually transient because products of these genes function as negative regulators of NF-êB, resulting in a negative feedback and limiting the duration of NF-êB activation (Figure 1). In certain diseases NF-êB activation becomes persistent, perhaps due to an interruption of this feedback loop.

NF-êB activation results in recruitment of the protein DSIF at the target genes A20 and IêBá. The researchers confirmed the role of DSIF in the negative feedback regulation of NF-êB activity by downregulating a protein subunit of DSIF and comparing the treated cells with controls. In untreated cells the levels of proteins for the target genes A20 and IêBá are high. Although the levels diminish significantly in 30 minutes following a process called TNF-á induction, which is caused by degradation of the proteins, within 2 hours the levels recover. In knockdown cells, however, the levels remained diminished 2 hours after TNF-á induction.

Further investigations using chromatin immunoprecipitation assays revealed abnormalities in the synthesis of A20 and IêBá proteins in the knock down cells. A significant portion of the A20 and IêBá mRNAs in the knockdown cells were uncapped and unspliced (Fig. 2).

The researchers also studied how export was affected in DSIF knockdown cells. Export of mature mRNAs from the nucleus to the cytoplasm is a highly regulated process incorporating quality assurance checks. The researchers prepared RNA from cytosolic and nuclear cell fractions for comparison. In knockdown cells following TNF-á induction, the nuclear fractions had much larger amounts of A20 and IêBá than the cytosolic fractions, suggesting accumulation in the nucleus.

The impact observed on the synthesis and export of A20 and IêBá in DSIF knockdown cells was striking. A20 and IêBá are also responsible for regulating other cell signalling processes and it is likely that the effects on associated signalling processes contribute to the overall impact of DSIF knockdown.

As the authors point out, diminished DSIF activity could contribute to pathological states in which NF-êB becomes constitutively active, such as inflammatory and autoimmune diseases, neurological disorders, and cancer. Further work on DSIF activity could help develop new approaches to treating these diseases.

Acknowledgments
These results were conducted as part of the JST's PRESTO project, "Epigenetic control and biological functions" (Research Supervisor: Dr. Tsunehiro Mukai, professor emeritus, Saga University).
Further information:
Yukiko Tokida
Center for Public Information, Tokyo Institute of Technology
2-12-1, Ookayama, Meguro-ku, Tokyo 152-8550, Japan
E-mail: kouhou@jim.titech.ac.jp
URL: http://www.titech.ac.jp/english/
Tel: +81-3-5734-2975
Fax: +81-3-5734-3661

About Tokyo Institute of Technology
As one of Japan’s top universities, Tokyo Institute of Technology seeks to contribute to civilization, peace and prosperity in the world, and aims at developing global human capabilities par excellence through pioneering research and education in science and technology, including industrial and social management. To achieve this mission, we have an eye on educating highly moral students to acquire not only scientific expertise but also expertise in the liberal arts, and a balanced knowledge of the social sciences and humanities, all while researching deeply from basics to practice with academic mastery. Through these activities, we wish to contribute to global sustainability of the natural world and the support of human life.
Associated links
http://www.titech.ac.jp/english/
Journal information
Gil Diamant, Liat Amir-Zilberstein, Yuki Yamaguchi, Hiroshi Handa, and Rivka Dikstein, “DSIF restricts NFêB signaling by coordinating elongation with mRNA processing of negative feedback genes” , Cell Reports, 2, (4), pp.722­731, (2012)

DOI: 10.1016/j.celrep.2012.08.041.

Adarsh Sandhu | Research asia research news
Further information:
http://www.titech.ac.jp/english/
http://www.researchsea.com

More articles from Health and Medicine:

nachricht Organ-on-a-chip mimics heart's biomechanical properties
23.02.2017 | Vanderbilt University

nachricht Researchers identify cause of hereditary skeletal muscle disorder
22.02.2017 | Klinikum der Universität München

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

From rocks in Colorado, evidence of a 'chaotic solar system'

23.02.2017 | Physics and Astronomy

'Quartz' crystals at the Earth's core power its magnetic field

23.02.2017 | Earth Sciences

Antimicrobial substances identified in Komodo dragon blood

23.02.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>